Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Monocytic, Acute × enasidenib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 2 Myeloproliferative Disorders 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1

Interventions

Injections 2 Decitabine 2 ruxolitinib 1 fludarabine 1 fedratinib 1 Whole-Body Irradiation 1 Thiotepa 1 Tacrolimus 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Methotrexate 1 Gemtuzumab 1 Daunorubicin 1 Cytarabine 1 Cyclosporins 1 Cyclosporine 1 Cyclophosphamide 1 Busulfan 1 Biopsy 1 Azacitidine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡